Advice You - Internet and Businesses Online

Email marketing is a tried and tested direct marketing strategy that involves marketing solutions through electronic ma

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

il (Email). Email marketing may be better understood in the context of offline world, where direct mails are sent to prospective custome

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

s, printed newsletters are mailed to subscribers and advertisements are printed in subscription magazines/ newspapers. The only differen

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ce is that of the medium in use.

Benefits
Email marketing uses electronic media that renders it much cheaper and

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

aster than any of its possible alternative mediums. It is a dynamic and interactive tool in the hands of the Internet marketers that may

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

be utilized innovatively to create and maintain customers without waiting for an initiative.

With a suitable website tracking software,

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

Email marketing can even be utilized to track down its effectiveness in terms of the number of visitors generated. Solicited Emails are

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

a reliable and smart way to stay in touch with the visitors to your website, who showed enough interest to leave their names and email a

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ddresses at your website for future record. Email marketing is particularly effective in reaching out to your business to business (B2B)

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

audience.

Negatives of Email Marketing
The picture, however, may not be desirably pleasant, if the marketing stra

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

egy is not implemented with finesse. It is frequently witnessed that Emails are not drafted with much caution, unlike in the case of its

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

offline version. As a result, the Emails are often marked as spam entries in the targeted inboxes without much thought. The worst part

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

s that companies still keep sending Emails to the same Email addresses, thereby running the risk of being blacklisted by the ISPs. The i

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

deal approach should be to build a long-term brand name rather than race to achieve a certain target statistic.

Types of Emails

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

/strong>
Double Opt-in, Single Opt-in and Double Opt-out are all solicited Emails, wherein explicit response from the recipient tri

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

gers the sending of the Emails. While Single Opt-in Email is sent when a user signs up for an Email subscription, Double Opt-in takes pl

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ace when he confirms his/ her subscription by responding to the automatically generated Email. Double Opt-out, on the other hand, concer

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

s unsubscribing wherein the recipient first unsubscribes and then confirms termination of the subscription.

Conclusion

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

Cheaper, interactive and forward-able – Email marketing spells nothing less than a revolution in the electronic marketing circles

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

hat can be timed and targeted to precision. It is all the way a boon for the marketers, only subject to polished and judicious use of it

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Advice You - Email Marketing - Lead Generation Through E-mails

Related Articles: